Invex Therapeutics (IXC.AX) Trading Summary
- Closing price (Saturday 24 th): AUD 0.10 (flat, 0 % change over 24 hours).
- Current trading price: AUD 0.10 on major exchanges.
- Shares outstanding: 75.2 million.
- Market capitalization: AUD 7.9 million.
- 24‑hour volume: AUD 4.6 k worth of shares traded.
- Month‑to‑date change: down 8.7 % since the previous month‑end.
- 200‑day simple moving average: AUD 0.11.
- 52‑week range:
- Highest: AUD 0.15 on 13 November 2025.
- Lowest: AUD 0.09 on 1 July 2026.
24‑Hour Performance of Related Stocks
| Stock | Symbol | 24‑hour change | Current price | Market cap |
|---|---|---|---|---|
| Greentech Metals | GRE.AX | –5.41 % | AUD 0.03 | AUD 9.4 million |
| Hawsons Iron | HIO.AX | +10 % | AUD 0.01 | AUD 9.3 million |
| Ava Risk | AVA.AX | –2.08 % | AUD 0.04 | AUD 9.4 million |
| Fulcrum Lithium | FUL.AX | 0 % | AUD 0.07 | AUD 9.4 million |
| Piche | PR2.AX | 0 % | AUD 0.03 | AUD 9.4 million |
Company Overview
Invex Therapeutics Ltd is an Australian biotechnology firm focused on therapeutics for neurological conditions and head injuries. Its product portfolio addresses raised intracranial pressure, idiopathic intracranial hypertension, and ruptured brain injuries, serving patients within Australia.
